Clinical Trial Update: REWARDS Premier Taxus-Liberte vs Xience V

View source ↗

Summary

A completed clinical trial comparing Taxus Liberte drug-eluting stents with Xience V drug-eluting stents in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Taxus Liberte (paclitaxel-eluting stent)
• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Coronary Artery Disease | Status: COMPLETED